Variant report
Variant | nsv947056 |
---|---|
Chromosome Location | chr1:224095132-224096718 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PARP1-4 | chr1:224096672-224097019 | expRegAs_chr1_21127_- |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564456598 | chr1:224095171-224095172 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528485681 | chr1:224095176-224095177 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4092529 | chr1:224095247-224095248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547634156 | chr1:224095260-224095261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200165286 | chr1:224095268-224095269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140469733 | chr1:224095287-224095288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9287000 | chr1:224095387-224095388 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs181669602 | chr1:224095433-224095434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375276037 | chr1:224095441-224095442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144435320 | chr1:224095462-224095463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537104784 | chr1:224095488-224095489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs202051933 | chr1:224095497-224095498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560480538 | chr1:224095534-224095535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369593547 | chr1:224095555-224095556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373025379 | chr1:224095556-224095557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141404880 | chr1:224095665-224095666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570395480 | chr1:224095676-224095677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534345855 | chr1:224095683-224095684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552580918 | chr1:224095708-224095709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs80277718 | chr1:224095728-224095729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3991825 | chr1:224095772-224095773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3991826 | chr1:224095783-224095784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs3991827 | chr1:224095796-224095797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3958384 | chr1:224095815-224095816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185953771 | chr1:224095830-224095831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535783145 | chr1:224095835-224095836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557126096 | chr1:224095870-224095871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs3872179 | chr1:224095900-224095901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs3991829 | chr1:224095909-224095910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs3991830 | chr1:224095955-224095956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3991831 | chr1:224096004-224096005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575434893 | chr1:224096010-224096011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs3872178 | chr1:224096020-224096021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs3991832 | chr1:224096036-224096037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs3872177 | chr1:224096076-224096077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564437340 | chr1:224096080-224096081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192436778 | chr1:224096092-224096093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540241557 | chr1:224096142-224096143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs3991834 | chr1:224096204-224096205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200270394 | chr1:224096286-224096287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562105678 | chr1:224096322-224096323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142892690 | chr1:224096384-224096385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530012879 | chr1:224096437-224096438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548508325 | chr1:224096457-224096458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113363274 | chr1:224096520-224096521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563434020 | chr1:224096565-224096566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530635727 | chr1:224096633-224096634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552223401 | chr1:224096676-224096677 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs570434866 | chr1:224096681-224096682 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs201423647 | chr1:224096687-224096688 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 20808228 | CNVD |
Fumarase deficiency | 21572526 | CNVD |
Autism | 17483303 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Leukoplakia | 24403051 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:224094400-224095200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr1:224094600-224095600 | Weak transcription | Fetal Thymus | thymus |
3 | chr1:224095600-224096200 | Enhancers | Fetal Thymus | thymus |
4 | chr1:224096000-224096200 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr1:224096200-224097400 | Weak transcription | Primary monocytes fromperipheralblood | blood |